Cases & Deals

Baxter Ventures invests in Zytoprotec

Clients Baxter International Inc.

Jones Day advised Baxter Ventures in connection with its investment in Zytoprotec GmbH, an Austrian biotechnology company applying findings in the area of cytoprotection to develop new treatment options for major diseases.